Mylan rejects Teva's $40 bln offer
April 27, 2015 at 09:31 AM EDT
April 27 (Reuters) - Mylan NV rejected Teva Pharmaceutical Industries Ltd's unsolicited $40 billion takeover offer, saying it "grossly undervalues" the company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.